hi all,
another new drug moves into competition.
Zepatier is approved for genotype 1 and 4. 12 weeks for most, at a 95%+
svr rate.
it is also 2 DAAs (ns5a inhibitor+protease inhibitor)
$54,000 for 12 weeks
hopefully this will leverage down prices, where we can finnally treat this monster in a timely manner.
every body have a great wekend!!!!
barry